Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1153)
Telix Pharmaceuticals Ltd (TLX)
Behrenbruch Christian — Director
Shares
33,435
Price
$14.87
Total Value
$497.18K
Shares Held After
20,742,935
% of Holdings
0.2%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
3,733
Price
$30.06
Total Value
$112.23K
Shares Held After
62,350
% of Holdings
5.6%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
3,700
Price
$30.06
Total Value
$111.23K
Shares Held After
153,169
% of Holdings
2.4%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
3,700
Price
$30.08
Total Value
$111.28K
Shares Held After
56,450
% of Holdings
6.2%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
3,830
Price
$30.07
Total Value
$115.17K
Shares Held After
384,237
% of Holdings
1.0%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
8,458
Price
$13.09
Total Value
$110.74K
Shares Held After
8,880
% of Holdings
48.8%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
100
Price
$1.75
Total Value
$175.00
Shares Held After
500
% of Holdings
20.0%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
7,500
Price
$25.37
Total Value
$190.30K
Shares Held After
10,503
% of Holdings
41.7%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
300
Price
$101.17
Total Value
$30.35K
Shares Held After
58,117
% of Holdings
0.5%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
700
Price
$100.14
Total Value
$70.10K
Shares Held After
58,417
% of Holdings
1.2%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
4,500
Price
$99.35
Total Value
$447.07K
Shares Held After
59,117
% of Holdings
7.1%
Kiniksa Pharmaceuticals International, plc (KNSA)
Patel Sanj K — Director
Shares
22,544
Price
$54.01
Total Value
$1.22M
Shares Held After
0
% of Holdings
100.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
12,170
Price
$5.63
Total Value
$68.52K
Shares Held After
283,305
% of Holdings
4.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
22
Price
$158.19
Total Value
$3.48K
Shares Held After
5,666
% of Holdings
0.4%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
102
Price
$157.39
Total Value
$16.05K
Shares Held After
5,688
% of Holdings
1.8%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
339
Price
$156.43
Total Value
$53.03K
Shares Held After
5,790
% of Holdings
5.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
259
Price
$155.52
Total Value
$40.28K
Shares Held After
6,129
% of Holdings
4.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
278
Price
$154.58
Total Value
$42.97K
Shares Held After
6,388
% of Holdings
4.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
457
Price
$573.89
Total Value
$262.27K
Shares Held After
40,513
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,654
Price
$572.89
Total Value
$947.57K
Shares Held After
40,970
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,786
Price
$572.06
Total Value
$1.02M
Shares Held After
42,624
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,432
Price
$570.87
Total Value
$1.39M
Shares Held After
44,410
% of Holdings
5.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,674
Price
$570.02
Total Value
$1.52M
Shares Held After
46,842
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
322
Price
$568.98
Total Value
$183.21K
Shares Held After
49,516
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
135
Price
$567.72
Total Value
$76.64K
Shares Held After
49,838
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
32
Price
$566.34
Total Value
$18.12K
Shares Held After
49,973
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
8
Price
$565.27
Total Value
$4.52K
Shares Held After
50,005
% of Holdings
0.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,000
Price
$1.11
Total Value
$5.55K
Shares Held After
280,766
% of Holdings
1.8%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
56,559
Price
$0.69
Total Value
$39.03K
Shares Held After
1,953,949
% of Holdings
2.8%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
35,000
Price
$17.62
Total Value
$616.70K
Shares Held After
1,786,039
% of Holdings
2.0%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
936
Price
$82.45
Total Value
$77.17K
Shares Held After
666,195
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
12,059
Price
$81.70
Total Value
$985.22K
Shares Held After
667,131
% of Holdings
1.8%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
17,005
Price
$80.74
Total Value
$1.37M
Shares Held After
679,190
% of Holdings
2.4%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$59.62
Total Value
$447.15K
Shares Held After
407,830
% of Holdings
1.8%
Telix Pharmaceuticals Ltd (TLX)
Behrenbruch Christian — Director
Shares
34,500
Price
$14.48
Total Value
$499.56K
Shares Held After
20,709,500
% of Holdings
0.2%
Kiniksa Pharmaceuticals International, plc (KNSA)
Patel Sanj K — Director
Shares
51,750
Price
$54.02
Total Value
$2.80M
Shares Held After
0
% of Holdings
100.0%
Kiniksa Pharmaceuticals International, plc (KNSA)
Patel Sanj K — Director
Shares
243,596
Price
$52.02
Total Value
$12.67M
Shares Held After
51,750
% of Holdings
82.5%
Kiniksa Pharmaceuticals International, plc (KNSA)
Patel Sanj K — Director
Shares
113,673
Price
$51.47
Total Value
$5.85M
Shares Held After
295,346
% of Holdings
27.8%
Kiniksa Pharmaceuticals International, plc (KNSA)
Patel Sanj K — Director
Shares
74,635
Price
$50.43
Total Value
$3.76M
Shares Held After
409,019
% of Holdings
15.4%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
1,875
Price
$49.78
Total Value
$93.33K
Shares Held After
40,136
% of Holdings
4.5%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
1,591
Price
$5.90
Total Value
$9.39K
Shares Held After
295,475
% of Holdings
0.5%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
32,916
Price
$49.78
Total Value
$1.64M
Shares Held After
0
% of Holdings
100.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
21
Price
$19.00
Total Value
$399.00
Shares Held After
1,158,923
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
1
Price
$19.00
Total Value
$19.00
Shares Held After
8,511
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
52
Price
$19.00
Total Value
$988.00
Shares Held After
4,939,437
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
26
Price
$19.00
Total Value
$494.00
Shares Held After
1,577,406
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
47,082
Price
$18.38
Total Value
$865.37K
Shares Held After
1,158,944
% of Holdings
3.9%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
1,170
Price
$18.38
Total Value
$21.50K
Shares Held After
8,512
% of Holdings
12.1%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
119,115
Price
$18.38
Total Value
$2.19M
Shares Held After
4,939,489
% of Holdings
2.4%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
59,870
Price
$18.38
Total Value
$1.10M
Shares Held After
1,577,432
% of Holdings
3.7%
Showing 51–100 of 1153 transactions (page 2 of 24)